192 related articles for article (PubMed ID: 34867338)
1. Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting.
Li L; Liu H; Tao W; Wen S; Fu X; Yu S
Front Pharmacol; 2021; 12():731386. PubMed ID: 34867338
[No Abstract] [Full Text] [Related]
2. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
4. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
[TBL] [Abstract][Full Text] [Related]
5. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
6. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
7. L-carnitine ameliorates the muscle wasting of cancer cachexia through the AKT/FOXO3a/MaFbx axis.
Wu C; Zhu M; Lu Z; Zhang Y; Li L; Li N; Yin L; Wang H; Song W; Xu H
Nutr Metab (Lond); 2021 Nov; 18(1):98. PubMed ID: 34724970
[TBL] [Abstract][Full Text] [Related]
8. Carnosol and its analogues attenuate muscle atrophy and fat lipolysis induced by cancer cachexia.
Lu S; Li Y; Shen Q; Zhang W; Gu X; Ma M; Li Y; Zhang L; Liu X; Zhang X
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):779-795. PubMed ID: 33951335
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model.
Chen L; Chen Y; Wang M; Lai L; Zheng L; Lu H
Eur J Pharmacol; 2024 Apr; 969():176429. PubMed ID: 38423241
[TBL] [Abstract][Full Text] [Related]
10. Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia.
Miao C; Zhang W; Feng L; Gu X; Shen Q; Lu S; Fan M; Li Y; Guo X; Ma Y; Liu X; Wang H; Zhang X
Mol Ther Nucleic Acids; 2021 Jun; 24():923-938. PubMed ID: 34094711
[TBL] [Abstract][Full Text] [Related]
11. IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway.
Liu D; Qiao X; Ge Z; Shang Y; Li Y; Wang W; Chen M; Si S; Chen SZ
Skelet Muscle; 2019 Mar; 9(1):8. PubMed ID: 30922397
[TBL] [Abstract][Full Text] [Related]
12. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
13. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.
Ubachs J; van de Worp WRPH; Vaes RDW; Pasmans K; Langen RC; Meex RCR; van Bijnen AAJHM; Lambrechts S; Van Gorp T; Kruitwagen RFPM; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):311-324. PubMed ID: 34951138
[TBL] [Abstract][Full Text] [Related]
15. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
[TBL] [Abstract][Full Text] [Related]
16. Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species.
Xu T; Yang X; Wu C; Qiu J; Fang Q; Wang L; Yu S; Sun H
J Thorac Dis; 2018 May; 10(5):2752-2759. PubMed ID: 29997937
[TBL] [Abstract][Full Text] [Related]
17. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
18. Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway.
Zhang H; Chi M; Chen L; Sun X; Wan L; Yang Q; Guo C
Front Pharmacol; 2020; 11():598166. PubMed ID: 33390985
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine Dithiocarbamate (PDTC) Attenuates Cancer Cachexia by Affecting Muscle Atrophy and Fat Lipolysis.
Miao C; Lv Y; Zhang W; Chai X; Feng L; Fang Y; Liu X; Zhang X
Front Pharmacol; 2017; 8():915. PubMed ID: 29311924
[TBL] [Abstract][Full Text] [Related]
20. Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.
Lala-Tabbert N; Lejmi-Mrad R; Timusk K; Fukano M; Holbrook J; St-Jean M; LaCasse EC; Korneluk RG
Skelet Muscle; 2019 May; 9(1):13. PubMed ID: 31126323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
